0
Skip to Content
Innovimmune Biotherapeutics
Platform
About
About Us
Management
Scientific Advisory Board
Pipeline
Our Pipeline
INV-25 LXR Agonist
INV-88 MIF Inhibitor
INV-17 ROR Gamma Inverse Agonist
INV-71 ROR Gamma Agonist
Media
News
Events
Contact
Partner with us
Innovimmune Biotherapeutics
Platform
About
About Us
Management
Scientific Advisory Board
Pipeline
Our Pipeline
INV-25 LXR Agonist
INV-88 MIF Inhibitor
INV-17 ROR Gamma Inverse Agonist
INV-71 ROR Gamma Agonist
Media
News
Events
Contact
Partner with us
Platform
Folder: About
Back
About Us
Management
Scientific Advisory Board
Folder: Pipeline
Back
Our Pipeline
INV-25 LXR Agonist
INV-88 MIF Inhibitor
INV-17 ROR Gamma Inverse Agonist
INV-71 ROR Gamma Agonist
Folder: Media
Back
News
Events
Contact
Partner with us

Scientific Advisory Board

Vincent Chung, M.D.

Professor
City of Hope Comprehensive Cancer Ctr

 

Christian Sebesta, M.D.

Professor & Chair
Klinik Donaustadt Medical Center

Partnering, advancing together

We are seeking strategic partnerships with pharmaceutical and biotechnology companies to advance Innovimmune’s novel therapeutic discoveries and accelerate R&D through clinical development, approval and commercialization.

Get in touch

INNOVIMMUNE
75 Wall Street, New York,
New York 10005, USA

Copyright © 2024 INNOVIMMUNE

Get in touch

Media Inquiries
media@innovimmune.com

Partnering & Licensing Inquiries
partnering@innovimmune.com